Cargando…
130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States
BACKGROUND: Multidrug-resistant (MDR) Shigella sonnei infections are a serious public health threat, and outbreaks are common among men who have sex with men (MSM). In February 2020, Australia’s Department of Health notified CDC of extensively drug-resistant (XDR) S. sonnei in 2 Australian residents...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776455/ http://dx.doi.org/10.1093/ofid/ofaa439.440 |
_version_ | 1783630687437324288 |
---|---|
author | Logan, Naeemah Z Karp, Beth E Tagg, Kaitlin A Burns-Lynch, Claire Chen, Jessica Garcia-Williams, Amanda Marsh, Zachary A O’Laughlin, Kevin Plumb, Ian D Schroeder, Morgan N Webb, Hattie E Zenas, Hannah Draper, Jenny Ginn, Andrew Martinez, Elena Partridge, Sally R Sim, Eby Sintchenko, Vitali Iredell, Jonathan Watkins, Louise Francois |
author_facet | Logan, Naeemah Z Karp, Beth E Tagg, Kaitlin A Burns-Lynch, Claire Chen, Jessica Garcia-Williams, Amanda Marsh, Zachary A O’Laughlin, Kevin Plumb, Ian D Schroeder, Morgan N Webb, Hattie E Zenas, Hannah Draper, Jenny Ginn, Andrew Martinez, Elena Partridge, Sally R Sim, Eby Sintchenko, Vitali Iredell, Jonathan Watkins, Louise Francois |
author_sort | Logan, Naeemah Z |
collection | PubMed |
description | BACKGROUND: Multidrug-resistant (MDR) Shigella sonnei infections are a serious public health threat, and outbreaks are common among men who have sex with men (MSM). In February 2020, Australia’s Department of Health notified CDC of extensively drug-resistant (XDR) S. sonnei in 2 Australian residents linked to a cruise that departed from Florida. We describe an international outbreak of XDR S. sonnei and report on trends in MDR among S. sonnei in the United States. METHODS: Health departments (HDs) submit every 20th Shigella isolate to CDC’s National Antimicrobial Resistance Monitoring System (NARMS) laboratory for susceptibility testing. We defined MDR as decreased susceptibility to azithromycin (MIC ≥32 µg/mL) with resistance to ampicillin, ciprofloxacin, and cotrimoxazole, and XDR as MDR with additional resistance to ceftriaxone. We used PulseNet, the national subtyping network for enteric disease surveillance, to identify US isolates related to the Australian XDR isolates by short-read whole genome sequencing. We screened these isolates for resistance determinants (ResFinder v3.0) and plasmid replicons (PlasmidFinder) and obtained patient histories from HDs. We used long-read sequencing to generate closed plasmid sequences for 2 XDR isolates. RESULTS: NARMS tested 2,781 S. sonnei surveillance isolates during 2011–2018; 80 (2.9%) were MDR, including 1 (0.04%) that was XDR. MDR isolates were from men (87%), women (9%), and children (4%). MDR increased from 0% in 2011 to 15.3% in 2018 (Figure). In 2020, we identified XDR isolates from 3 US residents on the same cruise as the Australians. The US residents were 41–42 year-old men; 2 with available information were MSM. The US and Australian isolates were highly related (0–1 alleles). Short-read sequence data from all 3 US isolates mapped to the bla(CTX-M-27) harboring IncFII plasmids from the 2 Australian isolates with >99% nucleotide identity. bla(CTX-M-27) genes confer ceftriaxone resistance. Increase in Percentage of Shigella sonnei Isolates with Multidrug Resistance* in the United States, 2011–2018† [Image: see text] CONCLUSION: MDR S. sonnei is increasing and is most often identified among men. XDR S. sonnei infections are emerging and are resistant to all recommended antibiotics, making them difficult to treat without IV antibiotics. This outbreak illustrates the alarming capacity for XDR S. sonnei to disseminate globally among at-risk populations, such as MSM. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-7776455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77764552021-01-07 130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States Logan, Naeemah Z Karp, Beth E Tagg, Kaitlin A Burns-Lynch, Claire Chen, Jessica Garcia-Williams, Amanda Marsh, Zachary A O’Laughlin, Kevin Plumb, Ian D Schroeder, Morgan N Webb, Hattie E Zenas, Hannah Draper, Jenny Ginn, Andrew Martinez, Elena Partridge, Sally R Sim, Eby Sintchenko, Vitali Iredell, Jonathan Watkins, Louise Francois Open Forum Infect Dis Poster Abstracts BACKGROUND: Multidrug-resistant (MDR) Shigella sonnei infections are a serious public health threat, and outbreaks are common among men who have sex with men (MSM). In February 2020, Australia’s Department of Health notified CDC of extensively drug-resistant (XDR) S. sonnei in 2 Australian residents linked to a cruise that departed from Florida. We describe an international outbreak of XDR S. sonnei and report on trends in MDR among S. sonnei in the United States. METHODS: Health departments (HDs) submit every 20th Shigella isolate to CDC’s National Antimicrobial Resistance Monitoring System (NARMS) laboratory for susceptibility testing. We defined MDR as decreased susceptibility to azithromycin (MIC ≥32 µg/mL) with resistance to ampicillin, ciprofloxacin, and cotrimoxazole, and XDR as MDR with additional resistance to ceftriaxone. We used PulseNet, the national subtyping network for enteric disease surveillance, to identify US isolates related to the Australian XDR isolates by short-read whole genome sequencing. We screened these isolates for resistance determinants (ResFinder v3.0) and plasmid replicons (PlasmidFinder) and obtained patient histories from HDs. We used long-read sequencing to generate closed plasmid sequences for 2 XDR isolates. RESULTS: NARMS tested 2,781 S. sonnei surveillance isolates during 2011–2018; 80 (2.9%) were MDR, including 1 (0.04%) that was XDR. MDR isolates were from men (87%), women (9%), and children (4%). MDR increased from 0% in 2011 to 15.3% in 2018 (Figure). In 2020, we identified XDR isolates from 3 US residents on the same cruise as the Australians. The US residents were 41–42 year-old men; 2 with available information were MSM. The US and Australian isolates were highly related (0–1 alleles). Short-read sequence data from all 3 US isolates mapped to the bla(CTX-M-27) harboring IncFII plasmids from the 2 Australian isolates with >99% nucleotide identity. bla(CTX-M-27) genes confer ceftriaxone resistance. Increase in Percentage of Shigella sonnei Isolates with Multidrug Resistance* in the United States, 2011–2018† [Image: see text] CONCLUSION: MDR S. sonnei is increasing and is most often identified among men. XDR S. sonnei infections are emerging and are resistant to all recommended antibiotics, making them difficult to treat without IV antibiotics. This outbreak illustrates the alarming capacity for XDR S. sonnei to disseminate globally among at-risk populations, such as MSM. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776455/ http://dx.doi.org/10.1093/ofid/ofaa439.440 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Abstracts Logan, Naeemah Z Karp, Beth E Tagg, Kaitlin A Burns-Lynch, Claire Chen, Jessica Garcia-Williams, Amanda Marsh, Zachary A O’Laughlin, Kevin Plumb, Ian D Schroeder, Morgan N Webb, Hattie E Zenas, Hannah Draper, Jenny Ginn, Andrew Martinez, Elena Partridge, Sally R Sim, Eby Sintchenko, Vitali Iredell, Jonathan Watkins, Louise Francois 130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States |
title | 130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States |
title_full | 130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States |
title_fullStr | 130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States |
title_full_unstemmed | 130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States |
title_short | 130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States |
title_sort | 130. increase in multidrug resistance (2011–2018) and the emergence of extensive drug resistance (2020) in shigella sonnei in the united states |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776455/ http://dx.doi.org/10.1093/ofid/ofaa439.440 |
work_keys_str_mv | AT logannaeemahz 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT karpbethe 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT taggkaitlina 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT burnslynchclaire 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT chenjessica 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT garciawilliamsamanda 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT marshzacharya 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT olaughlinkevin 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT plumbiand 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT schroedermorgann 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT webbhattiee 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT zenashannah 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT draperjenny 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT ginnandrew 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT martinezelena 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT partridgesallyr 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT simeby 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT sintchenkovitali 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT iredelljonathan 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates AT watkinslouisefrancois 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates |